This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down
by Zacks Equity Research
AMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.
BSXPositive Net Change AMNNegative Net Change WSTNegative Net Change EXASNegative Net Change
earnings medical medical-devices
Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care
by Debanjana Dey
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
HIMSNegative Net Change LFMDNegative Net Change TEMNegative Net Change
medical medical-devices
Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
BSXPositive Net Change WSTNegative Net Change EXASNegative Net Change DOCSNegative Net Change
earnings medical medical-devices
SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook
by Zacks Equity Research
Solventum posts strong Q3 results with a revenue and earnings beat, lifts 2025 EPS guidance on solid MedSurg and HIS growth.
BSXPositive Net Change MCKNegative Net Change ALCNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal
by Moumi Mondal
After a strong Q4 rebound, HOLX's Breast Health takes center stage in the company's upcoming private equity takeover.
BDXPositive Net Change HOLXNegative Net Change GEHCNegative Net Change
medical medical-devices
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
by Zacks Equity Research
QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.
BSXPositive Net Change QDELNegative Net Change WSTNegative Net Change EXASNegative Net Change
earnings medical medical-devices
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
INGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
BSXPositive Net Change WSTNegative Net Change INGNNegative Net Change EXASNegative Net Change
earnings medical medical-devices
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
BSXPositive Net Change WSTNegative Net Change PACBNegative Net Change EXASNegative Net Change
earnings medical medical-devices
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
by Zacks Equity Research
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
BSXPositive Net Change CNMDNegative Net Change WSTNegative Net Change EXASNegative Net Change
earnings medical medical-devices
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
by Zacks Equity Research
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
BSXPositive Net Change BDXPositive Net Change WSTNegative Net Change EXASNegative Net Change
earnings medical medical-devices
XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View
by Indrajit Bandyopadhyay
DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
BSXPositive Net Change XRAYPositive Net Change ALCNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View
by Zacks Equity Research
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
BSXPositive Net Change ALCNegative Net Change AVNSPositive Net Change SOLVPositive Net Change
earnings medical medical-devices
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
by Zacks Equity Research
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
BSXPositive Net Change MCKNegative Net Change ALCNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
by Zacks Equity Research
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
BSXPositive Net Change IDXXNegative Net Change ZBHNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract
by Zacks Equity Research
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
BSXPositive Net Change WSTNegative Net Change EXASNegative Net Change HIMSNegative Net Change
earnings medical medical-devices
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
by Zacks Equity Research
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
BSXPositive Net Change MASINegative Net Change WSTNegative Net Change EXASNegative Net Change
earnings medical medical-devices
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
by Zacks Equity Research
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
BSXPositive Net Change ALCNegative Net Change CLOVPositive Net Change SOLVPositive Net Change
earnings medical medical-devices
COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves
by Zacks Equity Research
Cencora's Q4 results top estimates with 15% EPS growth and stronger margins, as GLP-1 demand and the RCA acquisition fuel solid segment gains.
BSXPositive Net Change ALCNegative Net Change CORPositive Net Change SOLVPositive Net Change
earnings medical medical-devices
FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y
by Zacks Equity Research
Fresenius Medical Care's Q3 earnings and revenues beat estimates, fueled by margin gains and solid organic growth across segments.
BSXPositive Net Change ALCNegative Net Change FMSNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
by Zacks Equity Research
Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
BSXPositive Net Change ISRGPositive Net Change CRLNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?
by Moumi Mondal
BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Alphatec Stock?
by Zacks Equity Research
Investors need to pay close attention to ATEC stock based on the movements in the options market lately.
ATECPositive Net Change
medical-devices
Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum?
by Zacks Equity Research
AVAH's solid care-hour growth, stronger reimbursement rates and margin gains are likely to set the stage for another robust quarter.
ADUSNegative Net Change AVAHPositive Net Change EHABPositive Net Change BTSGPositive Net Change
medical medical-devices
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
by Zacks Equity Research
Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.
BSXPositive Net Change HCAPositive Net Change WSTNegative Net Change INSPNegative Net Change
earnings medical medical-devices
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Dentsply Sirona's Q3 results may reveal ongoing softness in U.S. demand and orthodontic segments despite steady cost control.
XRAYPositive Net Change CORPositive Net Change GMEDPositive Net Change SOLVPositive Net Change
medical medical-devices